References
1. Patel SY, Carbone J, Jolles S. The expanding field of secondary
antibody deficiency: causes, diagnosis, and management. Frontiers
in immunology. 2019;10:33.
2. Jolles S, Borrell R, Zouwail S, et al. Calculated globulin (CG) as a
screening test for antibody deficiency. Clinical & Experimental
Immunology. 2014;177(3):671-678.
3. Wood PM. Primary antibody deficiency syndromes. Current opinion
in hematology. 2010;17(4):356-361.
4. Bousfiha A, Jeddane L, Picard C, et al. Human inborn errors of
immunity: 2019 update of the IUIS phenotypical classification.Journal of clinical immunology. 2020;40(1):66-81.
5. Bonilla FA, Barlan I, Chapel H, et al. International Consensus
Document (ICON): common variable immunodeficiency disorders. The
Journal of Allergy and Clinical Immunology: In Practice.2016;4(1):38-59.
6. Resnick ES, Cunningham-Rundles C. The many faces of the clinical
picture of common variable immune deficiency. Current opinion in
allergy and clinical immunology. 2012;12(6):595-601.
7. Dhalla F, Misbah SA. Secondary antibody deficiencies. Current
opinion in allergy and clinical immunology. 2015;15(6):505-513.
8. Pecoraro A, Jolles S, Crescenzi L, et al. Validation of calculated
globulin (CG) as a screening test for antibody deficiency in an Italian
university hospital. Current Pharmaceutical Biotechnology.2018;19(9):728-733.
9. Piza CFSdT, Aranda CS, Solé D, Jolles S, Condino-Neto A. Serum
protein electrophoresis may be used as a screening tool for antibody
deficiency in children and adolescents. Frontiers in Immunology.2021;12:712637.
10. Youden WJ. Index for rating diagnostic tests. Cancer.1950;3(1):32-35.
11. Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most
appropriate test cut-off value: the case of tests with continuous
results. Biochemia medica. 2016;26(3):297-307.
12. Wilson JMG, Jungner G, Organization WH. Principles and practice of
screening for disease. 1968.
13. Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated
principles for screening based on a systematic review and consensus
process. Cmaj. 2018;190(14):E422-E429.
14. Agarwal S, Cunningham-Rundles C. Assessment and clinical
interpretation of reduced IgG values. Annals of Allergy, Asthma &
Immunology. 2007;99(3):281-283.
15. O’Connell T, Horita TJ, Kasravi B. Understanding and interpreting
the serum protein electrophoresis. American family physician.2005;71(1):105-112.
16. Ogryzlo M, Maclachlan M, Dauphinee J, Fletcher A. The serum proteins
in health and disease: filter paper electrophoresis. The American
Journal of Medicine. 1959;27(4):596-616.
17. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort
study of 148 patients with polyclonal gammopathy. Mayo Clin Proc .
2001;76(5):476-487.
18. Quinti I, Spadaro G, Jolles S, Condino-Neto A. The complexity of
primary antibody deficiencies. Frontiers in immunology.2021;12:635482.
19. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity
and mortality in common variable immune deficiency over 4 decades.Blood, The Journal of the American Society of Hematology.2012;119(7):1650-1657.
20. Graziano V, Pecoraro A, Mormile I, et al. Delay in diagnosis affects
the clinical outcome in a cohort of cvid patients with marked reduction
of iga serum levels. Clinical Immunology. 2017;180:1-4.
Table 1: Distribution of the clinics, patient diagnosis
and concomitant treatment according to IgG levels